Assessment of Relative Bioavailability of Moroctocog Alfa and Moroctocog Alfa (AF‐CC) in Subjects With Severe Hemophilia A

An open‐label, single‐dose, randomized, two‐period, crossover study comparing the pharmacokinetics of factor VIII activity in plasma (FVIII:C) after administration of an albumin‐free presentation of moroctocog alfa (test) and moroctocog alfa manufactured using the previous technique (reference) was...

Descripción completa

Detalles Bibliográficos
Autores principales: Korth‐Bradley, Joan, Rupon, Jeremy, Plotka, Anna, Charnigo, Robert, Rendo, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944578/
https://www.ncbi.nlm.nih.gov/pubmed/29575770
http://dx.doi.org/10.1111/cts.12544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944578/
https://www.ncbi.nlm.nih.gov/pubmed/29575770
http://dx.doi.org/10.1111/cts.12544

Ejemplares similares